Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

589 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
GluK2 Is a Target for Gene Therapy in Drug-Resistant Temporal Lobe Epilepsy.
Boileau C, Deforges S, Peret A, Scavarda D, Bartolomei F, Giles A, Partouche N, Gautron J, Viotti J, Janowitz H, Penchet G, Marchal C, Lagarde S, Trebuchon A, Villeneuve N, Rumi J, Marissal T, Khazipov R, Khalilov I, Martineau F, Maréchal M, Lepine A, Milh M, Figarella-Branger D, Dougy E, Tong S, Appay R, Baudouin S, Mercer A, Smith JB, Danos O, Porter R, Mulle C, Crépel V. Boileau C, et al. Ann Neurol. 2023 Oct;94(4):745-761. doi: 10.1002/ana.26723. Epub 2023 Jul 6. Ann Neurol. 2023. PMID: 37341588
A potential diagnostic pitfall: Primary synovial sarcoma of the central nervous system.
Tauziede-Espariat A, Macagno N, Pissaloux D, Figarella-Branger D, Appay R, Bochaton D, Tazi S, Kauv P, Hasty L, Métais A, Chrétien F, Varlet P. Tauziede-Espariat A, et al. Free Neuropathol. 2022 Apr 26;3:3-11. doi: 10.17879/freeneuropathology-2022-3811. eCollection 2022 Jan. Free Neuropathol. 2022. PMID: 37284151 Free PMC article.
Tailoring glioblastoma treatment based on longitudinal analysis of post-surgical tumor microenvironment.
Bastiancich C, Snacel-Fazy E, Fernandez S, Robert S, Stacchini R, Plantureux L, Boissonneau S, Testud B, Guillet B, Debarbieux F, Luche H, Figarella-Branger D, Estève MA, Tabouret E, Tchoghandjian A. Bastiancich C, et al. Among authors: figarella branger d. J Exp Clin Cancer Res. 2024 Nov 28;43(1):311. doi: 10.1186/s13046-024-03231-4. J Exp Clin Cancer Res. 2024. PMID: 39605004 Free PMC article.
Phenotypic and epigenetic heterogeneity in FGFR2-fused glial and glioneuronal tumours.
Métais A, Dangouloff-Ros V, Garcia J, Vannod-Michel Q, Csanyi M, Tauziède-Espariat A, Appay R, Maurage CA, Uro-Coste E, Meyronet D, Rigau V, Rousseau A, Chotard G, Hamelin J, Pierron G, Colin C, Ollivier M, Roques M, Provost C, Cottier JP, Pallud J, Chrétien F, Guida L, Blauwblomme T, Boddaert N, Varlet P, Edjlali M, Figarella-Branger D; contributors of the Biopathology RENOCLIP‐LOC network; of the Neuroradiological RENOCLIP‐LOC network. Métais A, et al. Among authors: figarella branger d. Neuropathol Appl Neurobiol. 2024 Dec;50(6):e13014. doi: 10.1111/nan.13014. Neuropathol Appl Neurobiol. 2024. PMID: 39511841 Free PMC article.
Predictive genomic and transcriptomic analysis on endoscopic ultrasound-guided fine needle aspiration materials from primary pancreatic adenocarcinoma: a prospective multicentre study.
Nicolle R, Canivet C, Palazzo L, Napoléon B, Ayadi M, Pignolet C, Cros J, Gourgou S, Selves J, Torrisani J, Dusetti N, Cordelier P, Buscail L, Bournet B; BACAP Consortium. Nicolle R, et al. EBioMedicine. 2024 Nov;109:105373. doi: 10.1016/j.ebiom.2024.105373. Epub 2024 Oct 8. EBioMedicine. 2024. PMID: 39383608 Free PMC article.
Survival Outcomes Associated With First-Line Procarbazine, CCNU, and Vincristine or Temozolomide in Combination With Radiotherapy in IDH-Mutant 1p/19q-Codeleted Grade 3 Oligodendroglioma.
Kacimi SEO, Dehais C, Feuvret L, Chinot O, Carpentier C, Bronnimann C, Vauleon E, Djelad A, Cohen-Jonathan Moyal E, Langlois O, Campone M, Ducloie M, Noel G, Cuzzubbo S, Taillandier L, Ramirez C, Younan N, Menei P, Dhermain F, Desenclos C, Ghiringhelli F, Bourg V, Ricard D, Faillot T, Appay R, Tabouret E, Nichelli L, Mathon B, Thomas A, Tran S, Bielle F, Alentorn A, Iorgulescu JB, Boëlle PY, Labreche K, Hoang-Xuan K, Sanson M, Idbaih A, Figarella-Branger D, Ducray F, Touat M; POLA Network. Kacimi SEO, et al. Among authors: figarella branger d. J Clin Oncol. 2025 Jan 20;43(3):329-338. doi: 10.1200/JCO.24.00049. Epub 2024 Oct 2. J Clin Oncol. 2025. PMID: 39356975
SMAC mimetic drives microglia phenotype and glioblastoma immune microenvironment.
Snacel-Fazy E, Soubéran A, Grange M, Joseph K, Colin C, Morando P, Luche H, Pagano A, Brustlein S, Debarbieux F, Toutain S, Siret C, van de Pavert SA, Rougon G, Figarella-Branger D, Ravi VM, Tabouret E, Tchoghandjian A. Snacel-Fazy E, et al. Among authors: figarella branger d. Cell Death Dis. 2024 Sep 15;15(9):676. doi: 10.1038/s41419-024-07056-z. Cell Death Dis. 2024. PMID: 39278921 Free PMC article.
CNS Embryonal Tumor with PLAGL Amplification, a New Tumor Type in Children and Adolescents: Insights from a Comprehensive MRI Analysis.
Tietze A, Bison B; European Society for Paediatric Oncology (SIOPE)-Brain Tumour Group; Engelhardt J, Fenouil T, Figarella-Branger D, Goebell E, Hakumäki J, Koscielniak E, Ludlow LE, Meyronet D, Nyman P, Øra I, Pesola J, Rauramaa T, Reddingius RE, Samuel D, Sexton-Oates A, Vasiljevic A, Wefers AK, Zamecnik J, Jones D, Keck MK, von Hoff K. Tietze A, et al. Among authors: figarella branger d. AJNR Am J Neuroradiol. 2024 Sep 13:ajnr.A8496. doi: 10.3174/ajnr.A8496. Online ahead of print. AJNR Am J Neuroradiol. 2024. PMID: 39271290
Brain tumoroids: treatment prediction and drug development for brain tumors with fast, reproducible and easy-to-use personalized models.
Soubéran A, Jiguet-Jiglaire C, Toutain S, Morando P, Baeza-Kallee N, Appay R, Boucard C, Graillon T, Meyer M, Farah K, Figarella-Branger D, Tabouret E, Tchoghandjian A. Soubéran A, et al. Among authors: figarella branger d. Neuro Oncol. 2024 Sep 10:noae184. doi: 10.1093/neuonc/noae184. Online ahead of print. Neuro Oncol. 2024. PMID: 39252580
589 results